Clinical trials

Submission status
Submission deadline

Nature Communications is interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we are inviting submissions of papers reporting interventional trials - we will consider phase I to phase IV clinical trials - including those yielding negative results for which primary end-points were not met.

We are particularly interested in studies first reporting primary and secondary outcomes of interventional clinical trials, but we would also consider long-term follow-up of published trials.

All manuscripts will be considered according to our editorial policies for clinical research. Further information can be found in our recent editorial. Unfortunately, we cannot guarantee that any individual paper will be included in the desired collection.

Submit manuscript
Submission guidelines
Manuscript editing services
A group of medical practitioners working on a laptop together

News and Comments


Non-communicable diseases

Infectious diseases